Public releases
2023

Outlook 2023-2024

2023/12/19 - Financial public releases

Read more

Virbac acquired a majority stake in Globion, a leading Indian poultry vaccines specialist

2023/11/02 - Financial public releases

Acquistion_Virbac_octobre_300x200.jpgOn November 1, we successfully finalized the acquisition of a majority stake in Globion. This transaction will bolster our position of animal health leader in India by extending Virbac India’s existing poultry portfolio to the growing segment of avian vaccines. 

Read more

2023 third quarter consolidated sales

2023/10/23 - Financial public releases

Revenue growth at the end of September at +2.8% at constant exchange rates and scope thanks to a strong activity rebound in the third quarter (+7.8% at constant exchange rates and scope).

Read more

Virbac will enter the fast-growing poultry vaccines segment in India

2023/10/09 - Financial public releases

Acquistion_Virbac_octobre_300x200.jpgVirbac announces the signing of an agreement to acquire Globion, a leading Indian poultry vaccines specialist. This transaction will bolster our position of animal health market leader in India by extending Virbac India’s existing poultry portfolio to the growing segment of avian vaccines.

Read more

2023 half year results

2023/09/28 - Financial public releases

Current operating income before R&D slightly improving throughout first half of 2023 in percentage of revenue

Read more

Virbac launches a share buyback program

2023/08/22 - Financial public releases

Following the decision of the board of directors on June 19, 2023 and its approval by the shareholder’s meeting, we are going to buy back 100,000 of our own shares (less than 1.25% of the capital). Main objective: to decrease the company's share capital by canceling treasury shares purchased.

Read more

2023 half-year results: publication postponed to end of September

2023/08/22 - Financial public releases

At the end of August, with our priority systems fully restored and functional following the June cyberattack, we will be able to publish our mid-year results on September 28 with a two-week delay.

Read more

2023 second quarter consolidated sales

2023/07/18 - Financial public releases

Revenue up about 2% during the second quarter and stable at the end of June despite two unfavorable one-off effects throughout the semester

Read more

Virbac reassesses its 2023 growth and Adjusted EBIT1 forecast

2023/07/03 - Financial public releases

Virbac reassesses its 2023 growth and Adjusted EBIT1 forecast

Read more

2023 first quarter consolidated sales

2023/04/17 - Financial public releases

Slight decline in first-quarter revenue primarily due to a base effect as well as a context of market slowdown

Read more